🔥🐔 BizChicken 🐔🔥
Learn About the Corporations Around You
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
Enliven Therapeutics, Inc.
Market Cap: High
Employees: Lowest
small molecule kinase inhibitors
Enliven Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing small molecule inhibitors for cancer treatment, including key products ELVN-001 and ELVN-002 under clinical trials.
Website
About | About | Directors | About | Contact | Contact | Careers | Careers | Careers | Jobs | Careers | About | Vision/Values
Symbol: ELVN
Recent Price: $22.39
Industry: Biotechnology
CEO: Mr. Samuel S. Kintz M.B.A.
Sector: Healthcare
Employees: 52
Address: 6200 Lookout Road, Boulder, CO 80301
Phone: 720 647 8519
Leadership
- Sam Kintz, Co-founder, Chief Executive Officer, and Member of the Board of Directors
- Joe Lyssikatos, Co-founder, Chief Scientific Officer
- Anish Patel, Co-founder and Chief Operating Officer
- Helen Collins, Chief Medical Officer
- Ben Hohl, Chief Financial Officer and Head of Corporate Development
- Galya Blachman, Chief Legal Officer and Head of Business Development
- Rich A. Heyman, Chairman of the Board of Directors
- Rishi Gupta, Member of the Board of Directors
- Andy Phillips, Member of the Board of Directors
- Mika Kakefuda Derynck, Member of the Board of Directors
- Jake Bauer, Member of the Board of Directors
- Rahul Ballal, Member of the Board of Directors
- Lori Kunkel, Member of the Board of Directors
- Brian Druker, Scientific Advisor
- Kevin Koch, Scientific Advisor
Last updated: 2024-12-31